Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
QNCX compared with LPCN: revenue, margins and what each company keeps, and the suppliers and customers both name
QNCX
Quince Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
QNCX
Quince Therapeutics, Inc.
vs
LPCN
Lipocine Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: QNCX, LPCN.
Role chip = supplier or customer
Source: SEC EDGAR
QNCX
Quince Therapeutics, Inc.
Change
30.06
▲
+2.56%
· post 30.06
Mkt cap
$31.5M
Revenue
—
Revenue
—
LPCN
Lipocine Inc.
Change
1.58
▲
+3.56%
· post 1.55
Closed
Nov 6 '26
Mkt cap
$17.4M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
vs
Compare
Closed
Nov 6 '26
QNCX
Quince Therapeutics, Inc.
vs
LPCN
Lipocine Inc.
30.06
▲
+2.56%
post 30.06
Price
1.58
▲
+3.56%
post 1.55
$31.5M
Mkt cap
$17.4M
—
Revenue
$2M
Q3 FY26
—
Revenue
$2M
FY25
Change
Change
QNCX
30.06
▲
+2.56%
vs
LPCN
1.58
▲
+3.56%
Closed
Nov 6 '26